-
1
-
-
84988850433
-
Vaccinate boys as well as girls against HPV: It works, and it may be cost effective
-
Prue G. Vaccinate boys as well as girls against HPV: it works, and it may be cost effective. BMJ 2014; 349:g4834.
-
(2014)
BMJ
, vol.349
, pp. g4834
-
-
Prue, G.1
-
4
-
-
84875976587
-
Optimal vaccine allocation for the early mitigation of pandemic influenza
-
Matrajt L, Halloran ME, Longini Jr. I.M. Optimal vaccine allocation for the early mitigation of pandemic influenza. PLoS Comput Biol 2013; 9:e1002964.
-
(2013)
PLoS Comput Biol
, vol.9
, pp. e1002964
-
-
Matrajt, L.1
Halloran, M.E.2
Longini, I.M.3
-
6
-
-
84959903301
-
Ministerio de salud y protección social grupo inmunoprevenibles
-
Bogota, Colombia: Ministerio de Salud y Protección Social
-
Ministerio de Salud y Protección Social Grupo Inmunoprevenibles. Jornada de vacunación contra el virus del papiloma humano. Bogota, Colombia: Ministerio de Salud y Protección Social, 2014:1-3.
-
(2014)
Jornada de Vacunación Contra El Virus Del Papiloma Humano
, pp. 1-3
-
-
-
7
-
-
84867401358
-
Measles still spreads in Europe: Who is responsible for the failure to vaccinate?
-
Carrillo-Santisteve P, Lopalco PL. Measles still spreads in Europe: who is responsible for the failure to vaccinate?. Clin Microbiol Infect 2012; 18(suppl 5):50-6.
-
(2012)
Clin Microbiol Infect
, vol.18
, pp. 50-56
-
-
Carrillo-Santisteve, P.1
Lopalco, P.L.2
-
9
-
-
85026960765
-
-
In: Raviglione M, ed. Tuberculosis: a comprehensive, international approach. New York: Informa HealthCare
-
Lönnroth K, Zignol M, Uplekar M. Controlling tuberculosis in large metropolitan settings - NewYork City. In: Raviglione M, ed. Tuberculosis: a comprehensive, international approach. New York: Informa HealthCare, 2006:1018-20.
-
(2006)
Controlling Tuberculosis in Large Metropolitan Settings - NewYork City
, pp. 1018-1020
-
-
Lönnroth, K.1
Zignol, M.2
Uplekar, M.3
-
10
-
-
84902602776
-
Tuberculosis control in New York City-A changing landscape
-
Macaraig M, Burzynski J, Varma JK. Tuberculosis control in New York City-A changing landscape. N Engl J Med 2014; 370:2362-5.
-
(2014)
N Engl J Med
, vol.370
, pp. 2362-2365
-
-
Macaraig, M.1
Burzynski, J.2
Varma, J.K.3
-
11
-
-
60349094121
-
Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model
-
Sander B, Nizam A, Garrison LP Jr, Postma MJ, Halloran ME, Longini Jr. I.M. Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value Health 2009; 12:226-33.
-
(2009)
Value Health
, vol.12
, pp. 226-233
-
-
Sander, B.1
Nizam, A.2
Garrison, L.P.3
Postma, M.J.4
Halloran, M.E.5
Longini, I.M.6
-
12
-
-
64349098448
-
Introduction of human papillomavirus (HPV) vaccination in Sweden
-
pii
-
Tegnell A, Dillner J, Andrae B. Introduction of human papillomavirus (HPV) vaccination in Sweden. Euro Surveill 2009; 14:pii:19119.
-
(2009)
Euro Surveill
, vol.14
, pp. 19119
-
-
Tegnell, A.1
Dillner, J.2
Andrae, B.3
-
13
-
-
84876008961
-
Quadrivalent human papillomavirus vaccine effectiveness: A Swedish national cohort study
-
Leval A, Herweijer E, Ploner A, et al. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. J Natl Cancer Inst 2013; 105: 469-74.
-
(2013)
J Natl Cancer Inst
, vol.105
, pp. 469-474
-
-
Leval, A.1
Herweijer, E.2
Ploner, A.3
-
15
-
-
84896730323
-
Type-specific human papillomavirus biological features: Validated model-based estimates
-
Baussano I, Elfstrom KM, Lazzarato F, et al. Type-specific human papillomavirus biological features: validated model-based estimates. PLoS One 2013; 8:e81171.
-
(2013)
PLoS One
, vol.8
, pp. e81171
-
-
Baussano, I.1
Elfstrom, K.M.2
Lazzarato, F.3
-
16
-
-
84892463356
-
Upscaling human papillomavirus vaccination in high-income countries: Impact assessment based on transmission model
-
Baussano I, Dillner J, Lazzarato F, Ronco G, Franceschi S. Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model. Infect Agent Cancer 2014; 9:4.
-
(2014)
Infect Agent Cancer
, vol.9
, pp. 4
-
-
Baussano, I.1
Dillner, J.2
Lazzarato, F.3
Ronco, G.4
Franceschi, S.5
-
17
-
-
84873365473
-
High-Throughput monitoring of human papillomavirus type distribution
-
Soderlund-Strand A, Dillner J. High-Throughput monitoring of human papillomavirus type distribution. Cancer Epidemiol Biomarkers Prev 2013; 22:242-50.
-
(2013)
Cancer Epidemiol Biomarkers Prev
, vol.22
, pp. 242-250
-
-
Soderlund-Strand, A.1
Dillner, J.2
-
18
-
-
76149140074
-
Concurrent infection with multiple human papillomavirus types: Pooled analysis of the IARC HPV Prevalence Surveys
-
Vaccarella S, Franceschi S, Snijders PJ, Herrero R, Meijer CJ, Plummer M. Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2010; 19:503-10.
-
(2010)
Cancer Epidemiol Biomarkers Prev
, vol.19
, pp. 503-510
-
-
Vaccarella, S.1
Franceschi, S.2
Snijders, P.J.3
Herrero, R.4
Meijer, C.J.5
Plummer, M.6
-
19
-
-
84862771858
-
Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study
-
Carozzi F, Ronco G, Gillio-Tos A, et al. Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study. Eur J Cancer 2012; 48:1633-7.
-
(2012)
Eur J Cancer
, vol.48
, pp. 1633-1637
-
-
Carozzi, F.1
Ronco, G.2
Gillio-Tos, A.3
-
20
-
-
79960122395
-
Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica
-
Vaccarella S, Franceschi S, Herrero R, et al. Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica. J Infect Dis 2011; 204:385-90.
-
(2011)
J Infect Dis
, vol.204
, pp. 385-390
-
-
Vaccarella, S.1
Franceschi, S.2
Herrero, R.3
-
21
-
-
84879798247
-
Clinical trials of human papillomavirus vaccines and beyond
-
Lehtinen M, Dillner J. Clinical trials of human papillomavirus vaccines and beyond. Nat Rev Clin Oncol 2013; 10:400-10.
-
(2013)
Nat Rev Clin Oncol
, vol.10
, pp. 400-410
-
-
Lehtinen, M.1
Dillner, J.2
-
22
-
-
79551558109
-
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males
-
Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011; 364:401-11.
-
(2011)
N Engl J Med
, vol.364
, pp. 401-411
-
-
Giuliano, A.R.1
Palefsky, J.M.2
Goldstone, S.3
-
23
-
-
84923039975
-
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women
-
Joura EA, Giuliano AR, Iversen OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015; 372:711-23.
-
(2015)
N Engl J Med
, vol.372
, pp. 711-723
-
-
Joura, E.A.1
Giuliano, A.R.2
Iversen, O.E.3
-
24
-
-
84908087933
-
Human papillomavirus vaccines: WHO position paper, October 2014
-
World Health Organization.
-
World Health Organization. Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec 2014; 89:465-91.
-
(2014)
Wkly Epidemiol Rec
, vol.89
, pp. 465-491
-
-
-
25
-
-
85026952706
-
-
Socialstyrelsen. Accessed 2 March
-
Socialstyrelsen. Tvådosschema för HPV-vaccin planeras från årsskiftet. http://www.socialstyrelsen.se/nyheter/2014september/tvadosschemaforhpv-vaccinplane rasfranarsskiftet. Accessed 2 March 2015.
-
(2015)
Tvådosschema för HPV-vaccin Planeras Från Årsskiftet
-
-
-
26
-
-
84896881444
-
-
Cancer incidence and mortality worldwide. IARC CancerBase. No. 11. Lyon. France: International Agency for Research on Cancer
-
Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide. IARC CancerBase. No. 11. Lyon, France: International Agency for Research on Cancer, 2013.
-
(2013)
GLOBOCAN 2012 v1.0
-
-
Ferlay, J.1
Soerjomataram, I.2
Ervik, M.3
-
27
-
-
80155195391
-
Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm Sweden before public HPV vaccination
-
Du J, Nasman A, Carlson JW, Ramqvist T, Dalianis T. Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination. Acta Oncol 2011; 50:1215-9.
-
(2011)
Acta Oncol
, vol.50
, pp. 1215-1219
-
-
Du, J.1
Nasman, A.2
Carlson, J.W.3
Ramqvist, T.4
Dalianis, T.5
-
28
-
-
84855163224
-
Sexspecific immunization for sexually transmitted infections such as human papillomavirus: Insights from mathematical models
-
Bogaards JA, Kretzschmar M, Xiridou M, Meijer CJ, Berkhof J, Wallinga J. Sexspecific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models. PLoS Med 2011; 8:e1001147.
-
(2011)
PLoS Med
, vol.8
, pp. e1001147
-
-
Bogaards, J.A.1
Kretzschmar, M.2
Xiridou, M.3
Meijer, C.J.4
Berkhof, J.5
Wallinga, J.6
-
29
-
-
84959912497
-
Background to a vaccination programme for the human papillomavirus in Sweden 2007
-
Socialstyrelsen
-
Socialstyrelsen. Background to a vaccination programme for the human papillomavirus in Sweden 2007. Stockholm, Sweden: National Board of Health and Welfare, 2008.
-
(2008)
Stockholm, Sweden: National Board of Health and Welfare
-
-
-
30
-
-
50849092853
-
Seroepidemiology as basis for design of a human papillomavirus vaccination program
-
Ryding J, French KM, Naucler P, Barnabas RV, Garnett GP, Dillner J. Seroepidemiology as basis for design of a human papillomavirus vaccination program. Vaccine 2008; 26:5263-8.
-
(2008)
Vaccine
, vol.26
, pp. 5263-5268
-
-
Ryding, J.1
French, K.M.2
Naucler, P.3
Barnabas, R.V.4
Garnett, G.P.5
Dillner, J.6
-
31
-
-
84919390466
-
Change in population prevalences of human papillomavirus after initiation of vaccination: The high-Throughput HPV monitoring study
-
Soderlund-Strand A, Uhnoo I, Dillner J. Change in population prevalences of human papillomavirus after initiation of vaccination: the high-Throughput HPV monitoring study. Cancer Epidemiol Biomarkers Prev 2014; 23:2757-64.
-
(2014)
Cancer Epidemiol Biomarkers Prev
, vol.23
, pp. 2757-2764
-
-
Soderlund-Strand, A.1
Uhnoo, I.2
Dillner, J.3
-
32
-
-
84866628242
-
Cross-protective efficacy of two human papillomavirus vaccines: A systematic review and meta-Analysis
-
Malagon T, Drolet M, Boily MC, et al. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-Analysis. Lancet Infect Dis 2012; 12:781-9.
-
(2012)
Lancet Infect Dis
, vol.12
, pp. 781-789
-
-
Malagon, T.1
Drolet, M.2
Boily, M.C.3
-
33
-
-
34548497655
-
Human papillomavirus and cervical cancer
-
Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370:890-907.
-
(2007)
Lancet
, vol.370
, pp. 890-907
-
-
Schiffman, M.1
Castle, P.E.2
Jeronimo, J.3
Rodriguez, A.C.4
Wacholder, S.5
-
34
-
-
84864521576
-
HPV vaccination for boys? Talking economic sense
-
Garattini L, van de Vooren K. HPV vaccination for boys?. Talking economic sense. J Sex Med 2012; 9:2195-6.
-
(2012)
J Sex Med
, vol.9
, pp. 2195-2196
-
-
Garattini, L.1
Van De Vooren, K.2
-
37
-
-
84926077197
-
UK committee recommends HPV vaccination for men who have sex with men
-
Kirby T. UK committee recommends HPV vaccination for men who have sex with men. Lancet Oncol 2015; 16:e7.
-
(2015)
Lancet Oncol
, vol.16
, pp. e7
-
-
Kirby, T.1
-
38
-
-
79952487617
-
Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study
-
Giuliano AR, Lee JH, Fulp W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011; 377:932-40.
-
(2011)
Lancet
, vol.377
, pp. 932-940
-
-
Giuliano, A.R.1
Lee, J.H.2
Fulp, W.3
|